BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12584571)

  • 1. Trans-activation of heparanase promoter by ETS transcription factors.
    Lu WC; Liu YN; Kang BB; Chen JH
    Oncogene; 2003 Feb; 22(6):919-23. PubMed ID: 12584571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
    Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1.
    Santiago FS; Khachigian LM
    Circ Res; 2004 Sep; 95(5):479-87. PubMed ID: 15297375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
    Lynch CC; Crawford HC; Matrisian LM; McDonnell S
    Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
    Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
    Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.
    Rutter JL; Mitchell TI; Butticè G; Meyers J; Gusella JF; Ozelius LJ; Brinckerhoff CE
    Cancer Res; 1998 Dec; 58(23):5321-5. PubMed ID: 9850057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
    Liu YN; Kang BB; Chen JH
    Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1.
    Hasegawa Y; Abe M; Yamazaki T; Niizeki O; Shiiba K; Sasaki I; Sato Y
    Biochem Biophys Res Commun; 2004 Mar; 316(1):52-8. PubMed ID: 15003510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
    Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
    Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of heparanase gene expression by estrogen in breast cancer.
    Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
    Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
    Zhang M; Maass N; Magit D; Sager R
    Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.